Trials / Sponsors / Aiping Shi
Aiping Shi
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Neoadjuvant Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer Triple Negative Breast Cancer (TNBC) | Phase 2 | 2021-09-20 |